Moderna in talks with FDA over Phase 4 Covid vaccine datanews2026-05-01T18:08:48+00:00May 1st, 2026|Endpoints News|
Amgen launches late-stage obesity trial in patients who switch from rival drugsnews2026-05-01T17:23:32+00:00May 1st, 2026|Endpoints News|
Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchnews2026-05-01T16:50:12+00:00May 1st, 2026|Endpoints News|
Save the date: Premium subscriber-exclusive Post-Hoc Livenews2026-05-01T15:23:08+00:00May 1st, 2026|Endpoints News|
Summit slips on ivonescimab’s apparent interim miss in sign of investor frustrationnews2026-05-01T13:10:55+00:00May 1st, 2026|Endpoints News|
J&J axes pair of CAR-T therapies for lymphoma, citing evolving marketnews2026-05-01T11:07:45+00:00May 1st, 2026|Endpoints News|
FDA’s oncology advisors vote against ‘new paradigm’ in AstraZeneca trialnews2026-04-30T18:56:01+00:00April 30th, 2026|Endpoints News|
Krazati fails confirmatory trial in colorectal cancer, putting approval at risknews2026-04-30T18:37:50+00:00April 30th, 2026|Endpoints News|
FDA, AstraZeneca prep for oncology adcommnews2026-04-29T18:32:20+00:00April 29th, 2026|Endpoints News|
Bristol Myers reaches a crossroads as a make-or-break year takes shapenews2026-04-29T15:33:16+00:00April 29th, 2026|Endpoints News|
